Intended for healthcare professionals

CCBYNC Open access
Research

Late adverse event reporting from medical device manufacturers to the US Food and Drug Administration: cross sectional study

BMJ 2025; 388 doi: https://doi.org/10.1136/bmj-2024-081518 (Published 12 March 2025) Cite this as: BMJ 2025;388:e081518

Linked Editorial

Active postmarketing device surveillance as a legislative priority

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: March 2025 to April 2025

Rendering graph...
AbstractFullPdf
Mar 2025134401538
Apr 202581166132
Total215567670